Comparison of the prognostic factors of total en bloc spondylectomy and total piecemeal spondylectomy in patients with Enneking stage III giant cell tumor in the thoracic and lumbar spine

被引:4
作者
Zhou, Hua [1 ,2 ,3 ]
Wu, Fengliang [1 ,2 ,3 ]
Dang, Lei [1 ,2 ,3 ]
Li, Yan [1 ,2 ,3 ]
Liu, Xiaoguang [1 ,2 ,3 ]
Liu, Zhongjun [1 ,2 ,3 ]
Wei, Feng [1 ,2 ,3 ]
机构
[1] Peking Univ Third Hosp, Dept Orthopaed, Beijing, Peoples R China
[2] Engn Res Ctr Bone & Joint Precis Med, Beijing, Peoples R China
[3] Beijing Key Lab Spinal Dis Res, Beijing, Peoples R China
关键词
Giant cell tumor; Spinal tumor; Local recurrence; Total en bloc spondylectomy; Surgical margins; RETROSPECTIVE ANALYSIS; BONE; RADIOTHERAPY; RECURRENCE; RESECTION;
D O I
10.1007/s00586-022-07455-w
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose To compare total en bloc spondylectomy with marginal margins against piecemeal spondylectomy with intralesional margins in the surgical treatment of Enneking stage III spinal giant cell tumor (GCT) in terms of local recurrence. Methods A retrospective survival analysis of patients with Enneking stage III GCT who underwent TES with marginal margins or total piecemeal spondylectomy with intralesional margins was performed between January 2006 and April 2020. Local recurrence-free survival (LRFS) was the time between the date of surgery and recurrence. Factors with p-values Results Sixty patients (25 men and 35 women) with a mean age of 35.6 (range 11-71) years were included. The mean follow-up duration was 93 (range 24-198) months. Two patients were lost to follow-up 6 and 14 years after the procedure. Over a 10-year period, the recurrence rate was 13.3%. The 2-, 5-, and 10-year LRFS rates were 95%, 88%, and 78%, respectively. Univariate analysis identified total piecemeal spondylectomy and no adjuvant radiotherapy as prognostic factors for LRFS. Multivariate Cox-regression models showed a significant association between local recurrence and total piecemeal spondylectomy and no adjuvant radiotherapy. Conclusion TES with marginal margins is better than total piecemeal spondylectomy with intralesional margins owing to its lower postoperative recurrence rate. Adjuvant radiotherapy should be administered to reduce postoperative recurrence rates.
引用
收藏
页码:254 / 260
页数:7
相关论文
共 25 条
[1]  
Boriani Stefano, 2018, J Spine Surg, V4, P668, DOI 10.21037/jss.2018.09.02
[2]   Giant Cell Tumor of the Mobile Spine A Review of 49 Cases [J].
Boriani, Stefano ;
Bandiera, Stefano ;
Casadei, Roberto ;
Boriani, Luca ;
Donthineni, Rakesh ;
Gasbarrini, Alessandro ;
Pignotti, Elettra ;
Biagini, Roberto ;
Schwab, Joseph H. .
SPINE, 2012, 37 (01) :E37-E45
[3]   Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum [J].
Bukata, Susan, V ;
Blay, Jean-Yves ;
Rutkowski, Piotr ;
Skubitz, Keith ;
Henshaw, Robert ;
Seeger, Leanne ;
Dai, Tian ;
Jandial, Danielle ;
Chawla, Sant .
SPINE, 2021, 46 (05) :277-284
[4]   En Bloc Resection Versus Intralesional Surgery in the Treatment of Giant Cell Tumor of the Spine [J].
Charest-Morin, Raphaele ;
Fisher, Charles G. ;
Varga, Peter P. ;
Gokaslan, Ziya L. ;
Rhines, Laurence D. ;
Reynolds, Jeremy J. ;
Dekutoski, Mark B. ;
Quraishi, Nasir A. ;
Bilsky, Mark H. ;
Fehlings, Michael G. ;
Chou, Dean ;
Germscheid, Niccole M. ;
Luzzati, Alessandro ;
Boriani, Stefano .
SPINE, 2017, 42 (18) :1383-1390
[5]   Primary tumors of the spine: a review of clinical features in 438 patients [J].
Dang, Lei ;
Liu, Xiaoguang ;
Dang, Gengting ;
Jiang, Liang ;
Wei, Feng ;
Yu, Miao ;
Wu, Fengliang ;
Liu, Zhongjun .
JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (03) :513-520
[6]   Spondylectomy for Giant Cell Tumor After Denosumab Therapy [J].
de Carvalho Cavalcante, Rodrigo Alves ;
Silva Marques, Romulo Alberto ;
dos Santos, Vinicius Goncalves ;
Sabino, Eduardo ;
Fraga, Ailton Cabral, Jr. ;
Zaccariotti, Vladimir Arruda ;
Arruda, Joao Batista ;
Fernandes, Yvens Barbosa .
SPINE, 2016, 41 (03) :E178-E182
[7]   The role of percutaneous transarterial embolization in the management of spinal bone tumors: a literature review [J].
Facchini, Giancarlo ;
Parmeggiani, Anna ;
Peta, Giuliano ;
Martella, Claudia ;
Gasbarrini, Alessandro ;
Evangelisti, Gisberto ;
Miceli, Marco ;
Rossi, Giuseppe .
EUROPEAN SPINE JOURNAL, 2021, 30 (10) :2839-2851
[8]   Giant cell tumors of the spine: has denosumab changed the treatment paradigm? [J].
Goldschlager, Tony ;
Dea, Nicolas ;
Boyd, Michael ;
Reynolds, Jeremy ;
Patel, Shreyaskumar ;
Rhines, Laurence D. ;
Mendel, Ehud ;
Pacheco, Marina ;
Ramos, Edwin ;
Mattei, Tobias A. ;
Fisher, Charles G. .
JOURNAL OF NEUROSURGERY-SPINE, 2015, 22 (05) :526-533
[9]   Clinical features and prognostic factors of pediatric spine giant cell tumors: report of 31 clinical cases in a single center [J].
Jia, Qi ;
Chen, Guanghui ;
Cao, Jiashi ;
Yang, Xinghai ;
Zhou, Zhenhua ;
Wei, Haifeng ;
Liu, Tielong ;
Xiao, Jianru .
SPINE JOURNAL, 2019, 19 (07) :1232-1241
[10]   Giant Cell Tumor of Cervical Spine Presenting as Acute Asphyxia Successful Surgical Resection After Down-Staging With Denosumab [J].
Kumar, Rajendra ;
Meis, Jeanne M. ;
Amini, Behrang ;
McEnery, Kevin W. ;
Madewell, John E. ;
Rhines, Laurence D. ;
Benjamin, Robert S. .
SPINE, 2017, 42 (10) :E629-E632